Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huashi Tongbi Prescription is a traditional Chinese medicine (TCM) herbal formula used primarily for the treatment of conditions characterized by "dampness" and "obstruction" in TCM theory. It is most commonly applied in the management of rheumatic diseases and has also been studied for diabetic peripheral neuropathy. The prescription typically contains a combination of herbs designed to dispel dampness, unblock meridians, promote circulation, and relieve pain. Its mechanism of action is based on multi-target modulation including anti-inflammatory effects, improvement of microcirculation, neuroprotection, and immune regulation according to TCM principles. The specific composition may vary but often includes herbs such as Poria (Fu Ling), Atractylodes (Bai Zhu), Coix seed (Yi Yi Ren), among others[7]. There are no well-established modern pharmacological targets or mechanisms defined in Western medicine terms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Huashi Tongbi Prescription.